Sarre S, Van Belle K, Smolders I, Krieken G, Michotte Y
Department of Pharmaceutical Chemistry and Drug Analysis, Pharmaceutical Institute, Brussels, Belgium.
J Pharm Biomed Anal. 1992 Oct-Dec;10(10-12):735-9. doi: 10.1016/0731-7085(91)80073-i.
Microdialysis sampling was used for the determination of the protein binding and the free therapeutic drug concentration of drugs in plasma in vitro. Several drugs with varying extent of protein binding and for which the plasma monitoring is important were studied. To mimic the in vivo situation, an artificial blood vessel was constructed and filled with spiked plasma circulating at the flow rate of human blood at 37 degrees C. The microdialysis probe (16 mm membrane length, 20000 MW cut off) was placed in the vessel and perfused with 0.9% NaCl at 5 microliters min-1. Dialysates were collected every 10 min and were analysed by reversed-phase LC with UV detection. The free concentration of the drug was calculated by correcting the concentration in the dialysate for the recovery of the probe, which was also determined in the artificial blood vessel after the experiment. The data confirm that microdialysis is a valid alternative technique for the determination of protein binding or free therapeutic plasma concentration of drugs on a comparative basis. Reference to literature values indicates that the results of the proposed method correspond reasonably well with accepted values.
微透析采样用于体外测定血浆中药物的蛋白结合率和游离治疗药物浓度。研究了几种蛋白结合程度不同且血浆监测很重要的药物。为模拟体内情况,构建了一条人工血管,并用加样血浆填充,使其在37℃下以人体血液流速循环。将微透析探针(膜长16mm,截留分子量20000)置于血管中,并用0.9%氯化钠以5微升/分钟的流速进行灌注。每10分钟收集一次透析液,并通过带紫外检测的反相液相色谱进行分析。通过对透析液中药物浓度进行探针回收率校正来计算药物的游离浓度,探针回收率在实验结束后也在人工血管中进行了测定。数据证实,微透析是一种在比较基础上测定药物蛋白结合率或游离治疗血浆浓度的有效替代技术。与文献值的对照表明,所提出方法的结果与公认值相当吻合。